Literature DB >> 21388892

Transcranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease.

Alex E Roher1, Zsolt Garami, Suzanne L Tyas, Chera L Maarouf, Tyler A Kokjohn, Marek Belohlavek, Linda J Vedders, Donald Connor, Marwan N Sabbagh, Thomas G Beach, Mark R Emmerling.   

Abstract

BACKGROUND: Multiple lines of evidence suggest that cardiovascular co-morbidities hasten the onset of Alzheimer's disease (AD) or accelerate its course.
METHODS: To evaluate the utility of cerebral vascular physical function and/or condition parameters as potential systemic indicators of AD, transcranial Doppler (TCD) ultrasound was used to assess cerebral blood flow and vascular resistance of the 16 arterial segments comprising the circle of Willis and its major tributaries.
RESULTS: Our study showed that decreased arterial mean flow velocity and increased pulsatility index are associated with a clinical diagnosis of presumptive AD. Cerebral blood flow impairment shown by these parameters reflects the global hemodynamic and structural consequences of a multifaceted disease process yielding diffuse congestive microvascular pathology, increased arterial rigidity, and decreased arterial compliance, combined with putative age-associated cardiovascular output declines.
CONCLUSIONS: TCD evaluation offers direct physical confirmation of brain perfusion impairment and might ultimately provide a convenient and a noninvasive means to assess the efficacy of medical interventions on cerebral blood flow or reveal incipient AD. In the near term, TCD-based direct assessments of brain perfusion might offer the prospect of preventing or mitigating AD simply by revealing patients who would benefit from interventions to improve circulatory system function.
Copyright © 2011 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21388892      PMCID: PMC3117072          DOI: 10.1016/j.jalz.2010.09.002

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  58 in total

1.  Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.

Authors:  Gene E Alexander; Kewei Chen; Pietro Pietrini; Stanley I Rapoport; Eric M Reiman
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

Review 2.  Women and coronary heart disease risk factors.

Authors:  Vera Bittner
Journal:  J Cardiovasc Risk       Date:  2002-12

3.  Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease.

Authors:  Alex E Roher; Chera Esh; Tyler A Kokjohn; Walter Kalback; Dean C Luehrs; James D Seward; Lucia I Sue; Thomas G Beach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-25       Impact factor: 8.311

Review 4.  Mild cognitive impairment as a diagnostic entity.

Authors:  R C Petersen
Journal:  J Intern Med       Date:  2004-09       Impact factor: 8.989

Review 5.  Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications.

Authors:  Ramón Cacabelos; Lucía Fernández-Novoa; Valter Lombardi; Lola Corzo; Victor Pichel; Yasuhiko Kubota
Journal:  Neurol Res       Date:  2003-09       Impact factor: 2.448

Review 6.  Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease.

Authors:  Walter Kalback; Chera Esh; Eduardo M Castaño; Afroza Rahman; Tyler Kokjohn; Dean C Luehrs; Lucia Sue; Raquel Cisneros; Francoise Gerber; Claudia Richardson; Bernd Bohrmann; Douglas G Walker; Thomas G Beach; Alex E Roher
Journal:  Neurol Res       Date:  2004-07       Impact factor: 2.448

7.  Atherosclerosis of cerebral arteries in Alzheimer disease.

Authors:  Alex E Roher; Chera Esh; Afroza Rahman; Tyler A Kokjohn; Thomas G Beach
Journal:  Stroke       Date:  2004-09-16       Impact factor: 7.914

Review 8.  Alzheimer disease and cerebrovascular pathology: an update.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

9.  Differentiation of multi-infarct and Alzheimer dementia by intracranial hemodynamic parameters.

Authors:  F Ries; R Horn; J Hillekamp; C Honisch; M König; L Solymosi
Journal:  Stroke       Date:  1993-02       Impact factor: 7.914

Review 10.  Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Authors:  Marc Evans; Aled Roberts; Steve Davies; Alan Rees
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more
  42 in total

Review 1.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

2.  Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β-related cognitive decline.

Authors:  Jun Hua; SeungWook Lee; Nicholas I S Blair; Michael Wyss; Jiri M G van Bergen; Simon J Schreiner; Sonja M Kagerer; Sandra E Leh; Anton F Gietl; Valerie Treyer; Alfred Buck; Roger M Nitsch; Klaas P Pruessmann; Hanzhang Lu; Peter C M Van Zijl; Marilyn Albert; Christoph Hock; Paul G Unschuld
Journal:  Neurobiol Aging       Date:  2019-01-10       Impact factor: 4.673

3.  Changes in intracranial venous blood flow and pulsatility in Alzheimer's disease: A 4D flow MRI study.

Authors:  Leonardo A Rivera-Rivera; Tilman Schubert; Patrick Turski; Kevin M Johnson; Sara E Berman; Howard A Rowley; Cynthia M Carlsson; Sterling C Johnson; Oliver Wieben
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

4.  The effects of transcranial LED therapy (TCLT) on cerebral blood flow in the elderly women.

Authors:  Afonso S I Salgado; Renato A Zângaro; Rodolfo B Parreira; Ivo I Kerppers
Journal:  Lasers Med Sci       Date:  2014-10-03       Impact factor: 3.161

5.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

6.  Proteomic differences in brain vessels of Alzheimer's disease mice: Normalization by PPARγ agonist pioglitazone.

Authors:  AmanPreet Badhwar; Rebecca Brown; Danica B Stanimirovic; Arsalan S Haqqani; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

7.  Carotid Plaque Strain Indices Were Correlated With Cognitive Performance in a Cohort With Advanced Atherosclerosis, and Traditional Doppler Measures Showed no Association.

Authors:  Carol C Mitchell; Stephanie M Wilbrand; Thomas D Cook; Nirvedh H Meshram; Catherine N Steffel; Rebecca Nye; Tomy Varghese; Bruce P Hermann; Robert J Dempsey
Journal:  J Ultrasound Med       Date:  2020-05-12       Impact factor: 2.153

8.  4D flow MRI for intracranial hemodynamics assessment in Alzheimer's disease.

Authors:  Leonardo A Rivera-Rivera; Patrick Turski; Kevin M Johnson; Carson Hoffman; Sara E Berman; Phillip Kilgas; Howard A Rowley; Cynthia M Carlsson; Sterling C Johnson; Oliver Wieben
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-25       Impact factor: 6.200

Review 9.  Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and aerobic fitness.

Authors:  Takashi Tarumi; Rong Zhang
Journal:  J Neurochem       Date:  2017-11-07       Impact factor: 5.372

10.  Refraction correction in 3D transcranial ultrasound imaging.

Authors:  Brooks D Lindsey; Stephen W Smith
Journal:  Ultrason Imaging       Date:  2014-01       Impact factor: 1.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.